JP2022512647A5 - - Google Patents

Info

Publication number
JP2022512647A5
JP2022512647A5 JP2021519612A JP2021519612A JP2022512647A5 JP 2022512647 A5 JP2022512647 A5 JP 2022512647A5 JP 2021519612 A JP2021519612 A JP 2021519612A JP 2021519612 A JP2021519612 A JP 2021519612A JP 2022512647 A5 JP2022512647 A5 JP 2022512647A5
Authority
JP
Japan
Prior art keywords
aureus
antigen
antibody
binding fragment
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021519612A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512647A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/055143 external-priority patent/WO2020076789A2/en
Publication of JP2022512647A publication Critical patent/JP2022512647A/ja
Publication of JP2022512647A5 publication Critical patent/JP2022512647A5/ja
Ceased legal-status Critical Current

Links

JP2021519612A 2018-10-09 2019-10-08 抗黄色ブドウ球菌(Staphylococcus aureus)抗体の組み合わせ Ceased JP2022512647A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862743490P 2018-10-09 2018-10-09
US62/743,490 2018-10-09
US201962833297P 2019-04-12 2019-04-12
US62/833,297 2019-04-12
PCT/US2019/055143 WO2020076789A2 (en) 2018-10-09 2019-10-08 Combinations of anti-staphylococcus aureus antibodies

Publications (2)

Publication Number Publication Date
JP2022512647A JP2022512647A (ja) 2022-02-07
JP2022512647A5 true JP2022512647A5 (cg-RX-API-DMAC7.html) 2022-10-18

Family

ID=70051346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021519612A Ceased JP2022512647A (ja) 2018-10-09 2019-10-08 抗黄色ブドウ球菌(Staphylococcus aureus)抗体の組み合わせ

Country Status (11)

Country Link
US (2) US11168133B2 (cg-RX-API-DMAC7.html)
EP (1) EP3864041A2 (cg-RX-API-DMAC7.html)
JP (1) JP2022512647A (cg-RX-API-DMAC7.html)
KR (1) KR20210072057A (cg-RX-API-DMAC7.html)
CN (1) CN113164602A (cg-RX-API-DMAC7.html)
AU (1) AU2019357983A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021006622A2 (cg-RX-API-DMAC7.html)
CA (1) CA3115633A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021004173A (cg-RX-API-DMAC7.html)
TW (1) TW202035443A (cg-RX-API-DMAC7.html)
WO (1) WO2020076789A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2917360B1 (en) * 2012-11-06 2020-01-08 Medlmmune, LLC Antibodies to s. aureus surface determinants
MX2021000889A (es) 2018-07-24 2021-04-28 Medimmune Llc Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus.
WO2020076790A1 (en) 2018-10-09 2020-04-16 Medimmune, Llc Antibodies directed against staphylococcus aureus leukotoxins
MX2021004173A (es) 2018-10-09 2021-09-08 Medimmune Llc Combinaciones de anticuerpos dirigidos contra staphylococcus aureus.
JP7682795B2 (ja) 2019-03-13 2025-05-26 メディミューン,エルエルシー コロニー形成患者における黄色ブドウ球菌(Staphylococcus aureus)感染症の低減
KR20230049584A (ko) * 2020-05-07 2023-04-13 플라이언트 테라퓨틱스, 인크. 아미노산 화합물을 사용한 호흡기 질환의 치료
CN117771379B (zh) * 2023-10-25 2024-08-30 珠海泰诺麦博制药股份有限公司 特异性结合金黄色葡萄球菌Hla毒素的全人源抗体与抗生素的组合
CN121537524B (zh) * 2026-01-20 2026-04-28 江西省人民医院 一种mda5人源化单克隆抗体及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7658921B2 (en) 2000-12-12 2010-02-09 Medimmune, Llc Molecules with extended half-lives, compositions and uses thereof
WO2002072600A2 (en) 2001-01-26 2002-09-19 Inhibitex, Inc. Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
AU2002368077B2 (en) 2001-07-12 2010-03-04 Jefferson Foote Super humanized antibodies
US20030226155A1 (en) 2001-08-30 2003-12-04 Biorexis Pharmaceutical Corporation Modified transferrin-antibody fusion proteins
US20040014194A1 (en) 2002-03-27 2004-01-22 Schering Corporation Beta-secretase crystals and methods for preparing and using the same
ATE458006T1 (de) 2003-05-14 2010-03-15 Kenta Biotech Ag Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa
CN1324049C (zh) 2003-08-04 2007-07-04 中国疾病预防控制中心病毒病预防控制所 人源抗sars冠状病毒基因工程抗体
WO2005100402A1 (en) 2004-04-13 2005-10-27 F.Hoffmann-La Roche Ag Anti-p-selectin antibodies
TW200813091A (en) 2006-04-10 2008-03-16 Amgen Fremont Inc Targeted binding agents directed to uPAR and uses thereof
JP2009539979A (ja) 2006-06-12 2009-11-19 ナビ バイオファーマシューティカルズ ブドウ球菌感染症を治療および予防するための、α毒素の使用
JP5675109B2 (ja) 2007-02-20 2015-02-25 アナプティスバイオ インコーポレイティッド ライブラリーの生成方法及びその使用
JP5718640B2 (ja) 2007-08-21 2015-05-13 アムジエン・インコーポレーテツド ヒトc−fms抗原結合性タンパク質
KR20100072228A (ko) 2007-08-31 2010-06-30 유니버시티 오브 시카고 스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
KR20110044991A (ko) 2008-07-02 2011-05-03 이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 TNF-α 길항제 다-표적 결합 단백질
EP2208787A1 (en) 2009-01-19 2010-07-21 Université de Liège A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
CN102387814A (zh) 2009-01-29 2012-03-21 米迪缪尼有限公司 延长体内半衰期的人抗il-6抗体及其在治疗肿瘤、自身免疫性疾病和炎症性疾病中的应用
LT3444268T (lt) 2010-05-05 2022-04-11 New York University Staphylococcus aureus leukocidinai, terapinės kompozicijos ir jų panaudojimo būdai
RS58190B2 (sr) 2011-02-08 2021-08-31 Medimmune Llc Antitela koja specifično vezuju staphylococcus aureus alfa toksin i postupci njihove primene
EP2917360B1 (en) 2012-11-06 2020-01-08 Medlmmune, LLC Antibodies to s. aureus surface determinants
ES2912267T3 (es) 2012-11-06 2022-05-25 Medimmune Llc Métodos de tratamiento de enfermedades asociadas a S. aureus
CN105873946A (zh) 2013-10-17 2016-08-17 阿尔萨尼斯生物科学有限责任公司 交叉反应性金黄色葡萄球菌抗体序列
JP6832709B2 (ja) 2014-05-16 2021-02-24 メディミューン,エルエルシー 新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
TWI719938B (zh) 2014-06-19 2021-03-01 美商麥迪紐有限責任公司 多重細菌感染之治療
AU2016249837A1 (en) 2015-04-17 2017-09-28 Arsanis Biosciences Gmbh Anti-staphylococcus aureus antibody combination preparation
US20190077851A1 (en) 2015-10-30 2019-03-14 Bruno Francois Methods of using anti-alpha toxin antibody
MX2021000889A (es) 2018-07-24 2021-04-28 Medimmune Llc Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus.
MX2021004173A (es) 2018-10-09 2021-09-08 Medimmune Llc Combinaciones de anticuerpos dirigidos contra staphylococcus aureus.
WO2020076790A1 (en) 2018-10-09 2020-04-16 Medimmune, Llc Antibodies directed against staphylococcus aureus leukotoxins

Similar Documents

Publication Publication Date Title
US12428473B2 (en) Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
US8653242B2 (en) Therapeutic antibodies against flagellated Pseudomonas aeruginosa
CN101910197B (zh) 针对铜绿假单胞菌pcrv抗原的抗体
JP2022105178A (ja) 黄色ブドウ球菌(staphylococcus aureus)感染症を治療および予防するための組成物および方法
US20150284450A1 (en) Combination therapies using anti-pseudomonas psl and pcrv binding molecules
JP2022512646A5 (cg-RX-API-DMAC7.html)
KR20100021577A (ko) 에스.아우레우스 ORF0657n을 표적화하는 항원 결합 단백질
EP1720908A2 (en) Super-humanized antibodies against respiratory syncytial virus
JP2019505527A5 (cg-RX-API-DMAC7.html)
CN104105708A (zh) PDGF受体β结合多肽
US8093360B2 (en) Antibodies that bind B. anthracis exotoxin, formulations thereof, and methods of use
JP2021530244A5 (cg-RX-API-DMAC7.html)
JP2013508292A5 (cg-RX-API-DMAC7.html)
WO2021052461A1 (zh) 抗α-溶血素的抗体及其应用
JP2016501877A5 (cg-RX-API-DMAC7.html)
JP2018529661A5 (cg-RX-API-DMAC7.html)
JP2023537078A5 (cg-RX-API-DMAC7.html)
JP2024535124A5 (cg-RX-API-DMAC7.html)
WO2022148480A1 (zh) 靶向金黄色葡萄球菌α-毒素的抗原结合蛋白及其应用
EP3224279B1 (en) Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the il-20r.
JP2022548881A5 (cg-RX-API-DMAC7.html)
RU2817697C1 (ru) Моноклональное антитело iC2 и его антигенсвязывающий фрагмент, селективно связывающие рецептор-связывающий домен Spike-белка вируса SARS-CoV-2, обладающие вируснейтрализующей активностью
RU2021112346A (ru) Комбинации антител к staphylococcus aureus
WO2024248127A1 (ja) アレルギー疾患予防・治療薬
WO2022140659A2 (en) Anti-cd47 antibodies and uses thereof